Marcia Allen - 16 Feb 2023 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role: Director
Signature: /s/ Marcia Allen
Issuer symbol: INMB
Transactions as of: 16 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 21 Feb 2023, 15:02:31 UTC
Previous filing: 23 Mar 2022
Next filing: 16 May 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INMB	Option (right to buy)	Award	$0	+35,000		$0.000000	35,000	16 Feb 2023	Common Stock	35,000	$9.74	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	19,024 options granted pursuant to the 2021 Stock Incentive Plan, 7,313 options granted pursuant to the 2019 Stock Incentive Plan and 8,663 options granted pursuant to the 2017 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.

Content

19,024 options granted pursuant to the 2021 Stock Incentive Plan, 7,313 options granted pursuant to the 2019 Stock Incentive Plan and 8,663 options granted pursuant to the 2017 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.